Market Overview:
The Global Digital Inhalers Market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the rising prevalence of respiratory diseases, growing awareness about digital inhalers, and technological advancements in digital inhalers. Based on type, the global digital inhalers market is segmented into metered dose inhaler (MDI) and dry powder inhaler (DPI). MDIs are further classified into manual and automatic devices. DPI is further classified into pressurized and non-pressurized devices. Based on application, the global digital inhalers market is segmented into hospital, clinic, and others. Others include home care settings and research institutes/laboratories. Geographically, the global digital inhalers market is segmented into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .
Product Definition:
A digital inhaler is a device that helps deliver medication to the lungs in the form of a mist or aerosol. This type of inhaler is often used to treat conditions like asthma and chronic obstructive pulmonary disease (COPD).
Metered Dose Inhaler (MDI):
MDI is a drug delivery technology that was initially designed for the treatment of obstructive airway disorders such as asthma. The metered dose inhaler (MDI) delivers precise doses of drugs to patients using an electronic counter-pressure metering valve. This technology minimizes underdose and overdose exposure, reduces medication errors, and improves patient compliance by simplifying the dosing technique.
Dry Powder Inhaler (DPI):
Dry powder inhaler (DPI) is a device used to deliver dry powder medication through the mouth using a compressed air stream. The main ingredient in DPI devices is an active pharmaceutical ingredient (API), which contains the drug or medicine that needs to be delivered. In addition, other ingredients such as colorants, flavors and inert gases are also added for therapeutic effect.
The advantages of using DPI include it being easy to use.
Application Insights:
Based on the application, the global demand for digital inhalers has been segmented into hospital, clinic and others. The hospital segment dominated the market in 2017 owing to factors such as increasing prevalence of respiratory disorders and growing awareness about asthma management. According to a study published by WHO in 2016, it was estimated that around 1 in 5 children globally suffers from asthma. Thus, increasing incidence of respiratory diseases coupled with rising awareness levels is expected to drive demand for inhalers at hospitals over the forecast period.
The Others segment includes care settings that do not have an established medical facility nearby or they are traveling without carrying their own inhaler along with them due to its convenience and ease of use.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to various factors such as technological advancements, high disposable income of patients, and availability of highly skilled physicians & healthcare professionals. Moreover, increasing demand for inhalers with reduced dosage forms and anesthetic gases is anticipated to drive growth in this region.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising product adoption by patients suffering from COPD coupled with government initiatives for control of chronic diseases such as asthma and COPD among others are some other factors driving regional growth. In addition, growing awareness about treatment options through various programs organized by governments or NGOs will boost revenue generation in this region over the next eight years (from 2018 To 2030).
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental conditions. This is expected to drive the demand for digital inhalers in the coming years.
- Growing awareness about asthma and COPD: There is a growing awareness among people about asthma and COPD, which is driving the demand for digital inhalers.
- Technological advancements: The technological advancements in digital inhalers are helping to improve their efficacy and patient compliance rates, thereby driving their growth in the market.
- Rising number of product approvals: The number of product approvals by regulatory agencies such as FDA is rising, which is aiding the growth of this market segment significantly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Digital Inhalers Market Research Report
By Type
Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI)
By Application
Hospital, Clinic, Others
By Companies
Novartis, Propeller Health (ResMed), AstraZeneca Plc, Philips Respironics, Opko Health, Teva Pharmaceuticals, Adherium, Glenmark Pharmaceuticals, Pneuma Respiratory
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Digital Inhalers Market Report Segments:
The global Digital Inhalers market is segmented on the basis of:
Types
Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Propeller Health (ResMed)
- AstraZeneca Plc
- Philips Respironics
- Opko Health
- Teva Pharmaceuticals
- Adherium
- Glenmark Pharmaceuticals
- Pneuma Respiratory
Highlights of The Digital Inhalers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Metered Dose Inhaler (MDI)
- Dry Powder Inhaler (DPI)
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Digital Inhalers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Digital inhalers are a type of medication delivery system that uses electronic sensors to measure the amount of medicine being delivered to the patient's lungs. This technology allows for precise dosing and reduces the risk of overdose.
Some of the major companies in the digital inhalers market are Novartis, Propeller Health (ResMed), AstraZeneca Plc, Philips Respironics, Opko Health, Teva Pharmaceuticals, Adherium, Glenmark Pharmaceuticals, Pneuma Respiratory.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Digital Inhalers Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Digital Inhalers Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Digital Inhalers Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Digital Inhalers Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Digital Inhalers Market Size & Forecast, 2020-2028 4.5.1 Digital Inhalers Market Size and Y-o-Y Growth 4.5.2 Digital Inhalers Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Metered Dose Inhaler (MDI)
5.2.2 Dry Powder Inhaler (DPI)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Digital Inhalers Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Digital Inhalers Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Metered Dose Inhaler (MDI)
9.6.2 Dry Powder Inhaler (DPI)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Metered Dose Inhaler (MDI)
10.6.2 Dry Powder Inhaler (DPI)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Metered Dose Inhaler (MDI)
11.6.2 Dry Powder Inhaler (DPI)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Metered Dose Inhaler (MDI)
12.6.2 Dry Powder Inhaler (DPI)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Metered Dose Inhaler (MDI)
13.6.2 Dry Powder Inhaler (DPI)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Digital Inhalers Market: Competitive Dashboard
14.2 Global Digital Inhalers Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Propeller Health (ResMed)
14.3.3 AstraZeneca Plc
14.3.4 Philips Respironics
14.3.5 Opko Health
14.3.6 Teva Pharmaceuticals
14.3.7 Adherium
14.3.8 Glenmark Pharmaceuticals
14.3.9 Pneuma Respiratory